Share this article
Share this article
BURLINGAME, Calif., April 9, 2021 /PRNewswire/ Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 2 SBIR grant from NIH NCATS, titled: Intelligent Chemical Structure Browser for Drug Discovery and Optimization . This is a continuation of the Phase 1 project announced in 2019.
Collaborative Drug Discovery, Inc. (CDD) has developed a novel intelligent data browser that will enable medicinal chemists developing new drug compounds to more efficiently browse and organize experimental data in an intuitive way that – for the first time – matches how they mentally map the relationships among the closely similar molecules that comprise a chemical lead series.
The time is now
April 8, 2021 12:35 p.m.
As Princeton University undergoes one of the most extensive building programs in its history over the next decade, it is using the opportunity to lay the foundation needed to achieve “net-zero” greenhouse gas emissions before mid-century. Pictured are some of the many projects aimed at cutting emissions and improving sustainability including geo-exchange, energy efficient new buildings, building efficiency improvements, photovoltaic solar energy, electric vehicle charging stations and all-electric buses. A key identifying the icons is available at the end of the story.
Image by Matilda Luk, Office of Communications; Google Earth Pro v 7.3.3.7786 (May 20, 2019) Princeton, New Jersey 40°20’52.49”N, 74°38’55.92”W Eye alt 2667ft https://earth.google.com [April 8, 2021]
I m a results-driven professional: NACOSEC deputy CEO lestimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lestimes.com Daily Mail and Mail on Sunday newspapers.
Elevation Oncology Announces Clinical Cancer Research Publication Highlighting the Specific Inhibition of HER3 by Seribantumab in Preclinical NRG1 Fusion Models
- Results show seribantumab efficiently inhibited HER3 and the entire ERBB family signaling pathway and established a biologically effective dose range for tumors driven by an NRG1 fusion -
- Seribantumab is currently being evaluated in the tumor-agnostic Phase 2 CRESTONE trial for patients with any solid tumor harboring an NRG1 fusion -
News provided by
Share this article
Share this article
NEW YORK, April 6, 2021 /PRNewswire/ Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, announced today the publication in
Mass Spectrometry Helps Identify Molecular Composition of Meteorites
Written by AZoOpticsApr 6 2021
In an effort to find the origin of carbonaceous chondrites the insoluble organic matter constituting the Murchison and Allende meteorites researchers from Russia and Germany investigated their molecular composition.
Сarbonaceous chondrite and its sulfur chemistry. Image Credit: Skoltech.
Using ultra-high resolution mass spectrometry, the team unraveled an extensive diversity of chemical compositions and unpredicted similarities between meteorites from various groups. The study has been published in the journal
Scientific Reports.
Carbonaceous chondrites are made of almost the whole spectrum of organic molecules found on Earth, such as nucleic acids that could have had a crucial role in the evolution of life.